ロード中...
Plasma kallistatin levels in patients with severe community-acquired pneumonia
INTRODUCTION: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) treatment commonly causes acute respiratory failure with high mortality. Kallistatin, an endogenous tissue kallikrein inhibitor, has been reported to be protective in various human diseases. The aim of this study wa...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4056893/ https://ncbi.nlm.nih.gov/pubmed/23394256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12507 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|